JOHANNESBURG, March 21 (Reuters) - South Africa has
concluded the sale of AstraZeneca COVID-19 vaccines it
had acquired but did not use to other African Union member
states, the health ministry said on Sunday.
The country in February decided not to use the AstraZeneca
shot after data showed it gave minimal protection against
mild-to-moderate infection caused by the country's dominant
coronavirus variant.
(Reporting by Olivia Kumwenda-Mtambo; Editing by Catherine
Evans)